What Does Brexit Mean for Health Care and Medical Research?
Tuesday, December 6, 2016 / 11:30 am - 12:30 pm


Margaret Anderson, Executive Director, FasterCures, a Center of the Milken Institute

Aisling Burnand, Chief Executive, Association of Medical Research Charities
Annalisa Jenkins, CEO, Dimension Therapeutics
Pierre Meulien, Executive Director, Innovative Medicines Initiative
Isabelle Moulon, Head of Public Engagement Department, European Medicines Agency

A new spirit of cooperation is propelling advances in medical research and improving health care. Parties who have traditionally viewed one another primarily as competitors, funders, suppliers or customers are joining forces to improve efficiency and leverage diverse perspectives. The result is more innovative medical products and better care. In this session, panelists will share how government and industry are collaborating, and they will report on progress in the movement to make patients partners in product development and care delivery. Panelists will explain why this matters for all of us and how this collaboration will advance precision medicine.